Literature DB >> 7818774

Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns.

V O Van Hoof1, M E De Broe.   

Abstract

Alkaline phosphatase (ALP, EC 3.1.3.1) is a membrane-bound metalloenzyme that consists of a group of true isoenzymes, all glycoproteins, encoded for by at least four different gene loci: tissue-nonspecific, intestinal, placental, and germ-cell ALP. Through posttranslational modifications of the tissue-nonspecific gene, for example, through differences in carbohydrate composition, bone and liver ALP are formed. Nowadays, most commercially available methods for separating or measuring ALP isoenzymes are easy to perform and sensitive and allow for reproducible and quantitative results. As more isoenzymes and isoforms have been characterized, confusion has arisen due to the many different names they were given. For the sake of simplicity and because of structural analogies, we propose an alternative nomenclature for the ALP isoenzymes and isoforms based on their structural characteristics: soluble, dimeric (Sol), anchor-bearing (Anch), and membrane-bound (Mem) liver, bone, intestinal, and placental ALP. Together with lipoprotein-bound liver ALP and immunoglobulin-bound ALP, these names largely fit the many forms of ALP one can encounter in human serum and tissues. The clinically relevant isoenzymes are sol-liver, Mem-liver, lipoprotein-bound liver, and Sol-intestinal ALP in liver diseases, and Sol-bone and Anch-bone ALP in bone diseases. Many different isoenzyme patterns can be found in malignancies and renal diseases. This test provides the clinician with valuable information for diagnostic purposes as well as for follow-up of patients and monitoring of treatment. However, ALP isoenzyme determination will only provide clinically useful information if the patterns are correctly interpreted. In this respect, care should be taken to use the proper reference ranges, taking into account the age and sex of the patient. A normal total ALP activity does not rule out the presence of an abnormal isoenzyme pattern, particularly in children. Separating ALP into its isoenzymes adds considerable value to the mere assay of total ALP activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7818774     DOI: 10.3109/10408369409084677

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  28 in total

1.  Multiple unfolding intermediates of human placental alkaline phosphatase in equilibrium urea denaturation.

Authors:  H C Hung; G G Chang
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and paget's specimens.

Authors:  Jila Masrour Roudsari; Soleiman Mahjoub
Journal:  Caspian J Intern Med       Date:  2012

3.  Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function.

Authors:  Katherine Ab Kellett; Jonathan Williams; Emma Rlc Vardy; A David Smith; Nigel M Hooper
Journal:  Int J Mol Epidemiol Genet       Date:  2011-02-10

4.  Alkaline Phosphatase: A Biomarker of Cardiac Function in Pediatric Patients.

Authors:  Elizabeth S Makil; Xinyu Tang; Elizabeth A Frazier; R Thomas Collins
Journal:  Pediatr Cardiol       Date:  2017-02-09       Impact factor: 1.655

5.  Non-enzymatic glycosylation of alkaline phosphatase alters its biological properties.

Authors:  A D McCarthy; A M Cortizo; G Giménez Segura; L Bruzzone; S B Etcheverry
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

6.  Quercus infectoria Gall Extract Enhanced the Proliferation and Activity of Human Fetal Osteoblast Cell Line (hFOB 1.19).

Authors:  Hermizi Hapidin; Dalila Rozelan; Hasmah Abdullah; Wan Nurhidayah Wan Hanaffi; Ima Nirwana Soelaiman
Journal:  Malays J Med Sci       Date:  2015 Jan-Feb

7.  Repeated serum alkaline phosphatase measurements in the treatment of childhood acute bone and joint infections with high doses of antibiotics.

Authors:  Markus Pääkkönen; Markku J T Kallio; Pentti E Kallio; Heikki Peltola
Journal:  Ann Lab Med       Date:  2013-08-08       Impact factor: 3.464

8.  Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer.

Authors:  Motohiro Tamiya; Hidekazu Suzuki; Masashi Kobayashi; Shinji Sasada; Norio Okamoto; Naoko Morishita; Tomomi Yasue; Yuka Matsuura; Tomonori Hirashima; Ichiro Kawase
Journal:  Med Oncol       Date:  2011-01-22       Impact factor: 3.064

Review 9.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

10.  Parathyroid hormone as a marker for metabolic bone disease of prematurity.

Authors:  A Moreira; L Swischuk; M Malloy; D Mudd; C Blanco; C Geary
Journal:  J Perinatol       Date:  2014-05-29       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.